A Preview Of Collegium Pharmaceutical's Earnings

Collegium Pharmaceutical (NASDAQ:COLL) is set to give its latest quarterly earnings report on Thursday, 2024-11-07. Here's what investors need to know before the announcement.

Analysts estimate that Collegium Pharmaceutical will report an earnings per share (EPS) of $1.59.

Anticipation surrounds Collegium Pharmaceutical's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.

New investors should understand that while earnings performance is important, market reactions are often driven by guidance.

Earnings History Snapshot

Last quarter the company beat EPS by $0.11, which was followed by a 0.51% increase in the share price the next day.

Here's a look at Collegium Pharmaceutical's past performance and the resulting price change:

Quarter

Q2 2024

Q1 2024

Q4 2023

Q3 2023

EPS Estimate

1.51

0.75

0.66

0.52

EPS Actual

1.62

1.45

1.58

1.34

Price Change %

1.0%

-17.0%

11.0%

7.000000000000001%

Collegium Pharmaceutical Share Price Analysis

Shares of Collegium Pharmaceutical were trading at $33.42 as of November 05. Over the last 52-week period, shares are up 42.5%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.

Analyst Views on Collegium Pharmaceutical

For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Collegium Pharmaceutical.

The consensus rating for Collegium Pharmaceutical is Buy, derived from 4 analyst ratings. An average one-year price target of $41.5 implies a potential 24.18% upside.

Comparing Ratings with Competitors

The ...